About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Tsubota Laboratory Incorporated(4890) Summary

4890
TSE Growth
Tsubota Laboratory Incorporated
340
JPY
-15
(-4.23%)
Apr 4, 3:30 pm JST
2.32
USD
Apr 4, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
79.2
PBR
5.95
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 4, 2025
Opening Apr 4, 9:03 am
339 JPY 2.31 USD
Previous Close Apr 3
355 JPY 2.41 USD
High Apr 4, 9:31 am
352 JPY 2.40 USD
Low Apr 4, 9:06 am
335 JPY 2.28 USD
Volume
123,700
Trading Value
0.04B JPY 0.29M USD
VWAP
342.17 JPY 2.34 USD
Minimum Trading Value
34,000 JPY 232 USD
Market Cap
8.72B JPY 0.06B USD
Number of Trades
215
Liquidity & Number of Trades
As of Apr 4, 2025
Liquidity
Mid
1-Year Average
291
1-Year High Jul 11, 2024
7,790
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 28, 2025 0 762,500
Mar 21, 2025 0 784,400
Mar 14, 2025 0 790,100
Mar 7, 2025 0 790,200
Feb 28, 2025 0 853,700
Company Profile
Tsubota Laboratory Incorporated is a biotech venture originating from Keio University. The company focuses on research and development of pharmaceuticals for myopia, dry eye, presbyopia, and brain activation.
Sector
Pharmaceuticals
Tsubota Laboratory Incorporated, a biotech venture born out of Keio University School of Medicine, aims to create groundbreaking innovations in the treatment of myopia, dry eye, presbyopia, and brain-related disorders. The company conducts advanced research in collaboration with affiliated universities and pursues joint development with partner companies to evaluate research outcomes. Its business model is based on generating revenue through joint research and development agreements, licensing agreements, upfront payments, milestone payments, and post-commercialization royalties, which are then reinvested into new research in a cyclical manner. A distinctive feature of the company is its research and development utilizing the high-level expertise of external contracted researchers. Tsubota Laboratory Incorporated adopts a dual strategy, simultaneously developing and marketing pharmaceuticals and medical devices alongside commodity products.